Price (delayed)
$68.36
Market cap
$12.63B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.96
Enterprise value
$14.86B
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer. Exact Sciences Corp. launched Cologuard in 2014, the first
There are no recent dividends present for EXAS.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from and Sharadar.